Form4insider filings, from the source

Insider holders · CIK 0000835887

PROGENICS PHARMACEUTICALS INC · PGNX

Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity

InsiderDirect sharesIndirect sharesTotal reportedLast report (ET)From
Kevin Kotler10% Owner6,997,269—6,997,269Feb 15, 2017 · 5:13 pm ESTForm 4
Broadfin Capital, LLC10% Owner6,997,269—6,997,269Feb 15, 2017 · 5:13 pm ESTForm 4
Broadfin Healthcare Master Fund Ltd10% Owner6,997,269—6,997,269Feb 15, 2017 · 5:13 pm ESTForm 4
Paul J MaddonDirector909,891—909,891Apr 22, 2016 · 5:09 pm EDTForm 4/A
Robert J IsraelExecutive Vice President, Medi35,050—35,050Jun 15, 2015 · 9:32 am EDTForm 4
Benedict OsorioSenior Vice President, Quality21,202—21,202Mar 2, 2018 · 2:08 pm ESTForm 3
Vivien WongExecutive Vice President4,121—4,121Apr 1, 2015 · 9:22 am EDTForm 3
Asha DasChief Medical Officer0—0Jan 11, 2019 · 9:51 am ESTForm 3
Bryce TenbargeVice President, Commercial0—0Aug 25, 2016 · 12:04 pm EDTForm 3

Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.